Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Response Biomedical Corp T.RBM

Sector: Healthcare | Sub-Sector: Medical Devices
Alternate Symbol(s):  RPBIF

Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets.
Price: $1.23 | Change: $-0.02 | %Change: -1.60%
Volume: 28,999 | Day High/Low: 1.23/1.21 | 52 Week High/Low: 2.68/1.20

Snapshot

Last Traded: October 01, 2014 10:08 Transaction Volume: 28,999
Open: $1.23 Previous Close: $1.25
Bid: $1.18 Ask: $1.25
Bid Size: 300 Ask Size: 200
Market Cap: $9.8m Shares Out: 7.9m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • hurting20

    0 stars

    Used to hold rbm...back when bld was all the rage. But hurting, what is with pli? Are you following it? Just curious.

    0.5 stars


  • Maybe Hippygirl

    0 stars

    But only because I knew it was all BS

    2.5 stars


  • RE:Wow Dimar

    0 stars

    Hurting20, no need for research. We both lived through the Radvak years. You made good money at that time. Remember? You named the Fab 4...

    4 stars


  • Wow Dimar

    0 stars

    You obviously are not as stupid as your post...so the only conclusion is you are a homey. There is nothing here going as planned...

    2.5 stars


  • In any case RBM is moving ahead

    0 stars

    I think RBM has become a more clearly focus company than it has ever been since Orbimed has taken control.  They made the decision to...

    3 stars